Edition:
India

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Global Select Market

4.07USD
11:47pm IST
Change (% chg)

$0.02 (+0.49%)
Prev Close
$4.05
Open
$4.10
Day's High
$4.13
Day's Low
$4.03
Volume
206,641
Avg. Vol
310,014
52-wk High
$7.21
52-wk Low
$2.87

Latest Key Developments (Source: Significant Developments)

Biodelivery Sciences International Files For Mixed Shelf Of Up to $125 Mln
Tuesday, 30 Jul 2019 

July 29 (Reuters) - BioDelivery Sciences International Inc ::BIODELIVERY SCIENCES INTERNATIONAL INC FILES FOR MIXED SHELF OF UPTO $125 MILLION - SEC FILING.BIODELIVERY SCIENCES INTERNATIONAL INC SAYS IN ADDITION, SELLING STOCKHOLDER OFFERING 12.8 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Biodelivery Sciences International Will Not Receive Any Of Proceeds From Sale Of Shares Of Common Stock By Selling Stockholder
Thursday, 11 Apr 2019 

April 10 (Reuters) - BioDelivery Sciences International Inc ::BIODELIVERY SCIENCES INTERNATIONAL, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.BIODELIVERY SCIENCES INTERNATIONAL INC - BDSI WILL NOT RECEIVE ANY OF PROCEEDS FROM SALE OF SHARES OF COMMON STOCK BY SELLING STOCKHOLDER..  Full Article

Biodelivery Sciences Acquires U.S. Commercial Rights To Symproic
Thursday, 11 Apr 2019 

April 10 (Reuters) - BioDelivery Sciences International Inc ::BIODELIVERY SCIENCES ACQUIRES U.S. COMMERCIAL RIGHTS TO SYMPROIC®.BIODELIVERY SCIENCES ACQUIRES U.S. COMMERCIAL RIGHTS TO SYMPROIC®.BIODELIVERY SCIENCES INTERNATIONAL INC - TOTAL 2019 COMPANY NET SALES EXPECTED TO BE $92-$100 MILLION WITH SYMPROIC NET SALES OF $7-$9 MILLION.BIODELIVERY SCIENCES INTERNATIONAL INC - WILL PAY SHIONOGI, INC., AN INITIAL PAYMENT OF $20 MILLION AND AN ADDITIONAL $10 MILLION IN SIX MONTHS.BIODELIVERY SCIENCES INTERNATIONAL INC - SHIONOGI IS ELIGIBLE TO RECEIVE TIERED ROYALTY PAYMENTS BASED ON NET SALES OF SYMPROIC.BIODELIVERY SCIENCES INTERNATIONAL INC - COMPANY HAS REAFFIRMED ITS EXPECTATION TO BECOME OPERATING CASH FLOW POSITIVE BY END OF 2019..BIODELIVERY SCIENCES INTERNATIONAL INC - EXPECTS LONG-TERM NET SALES POTENTIAL OF ITS PRODUCT PORTFOLIO TO BE IN RANGE OF $325 - $400 MILLION.BIODELIVERY SCIENCES INTERNATIONAL INC - EXPECT TO SEE AN ACCRETIVE CONTRIBUTION TO CASH FLOW IN FIRST HALF OF 2020 FROM SYMPROIC.  Full Article

Biodelivery Sciences Says On March 1, Bdsi Filed Complaint For Patent Infringement In Delaware
Monday, 4 Mar 2019 

March 4 (Reuters) - BioDelivery Sciences International Inc ::BIODELIVERY SCIENCES INTERNATIONAL - ON MARCH 1, 2019, BDSI FILED A COMPLAINT FOR PATENT INFRINGEMENT IN DELAWARE - SEC FILING.BIODELIVERY SCIENCES INTERNATIONAL - COMPLAINT WAS FILED AGAINST CHEMO RESEARCH, S.L., INSUD PHARMA S.L., INTELGENX CORP., AND INTELGENX TECHNOLOGIES.BIODELIVERY SCIENCES INTERNATIONAL - BELIEVES THAT IT WILL BE ABLE TO PREVAIL IN PATENT INFRINGEMENT LAWSUIT.  Full Article

Biodelivery Sciences International Files For Mixed Shelf Of Up To $150 Mln
Friday, 9 Nov 2018 

Nov 9 (Reuters) - BioDelivery Sciences International Inc ::BIODELIVERY SCIENCES INTERNATIONAL INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING.  Full Article

BRIEF-Biodelivery Sciences Says Frank O'Donnell Jr Notified That He Has Decided To Resign

* BIODELIVERY SCIENCES INTERNATIONAL INC - FRANK E. O'DONNELL JR NOTIFIED CO THAT HE HAS DECIDED TO RESIGN Source text: (https://bit.ly/2zu0UjM) Further company coverage: